Promoting and facilitating strategies to improve cardiovascular health worldwide

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar











ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

Optimal Antiplatelet Therapy In NSTE-ACS: Results From A Novel Crowdsourcing Survey

Posted on July 07, 2021

The choice and duration of antiplatelet therapy in NSTE-ACS undergoing PCI is complex and is a hotly debated topic – particularly amongst... more

Dapagliflozin safely reduces kidney failure risk, cardiovascular mortality in advanced CKD

Posted on July 27, 2021

An analysis of DAPA-CKD data showed dapagliflozin reduces the risk for kidney failure and mortality in patients with advanced chronic kidney disease,... more

Cleveland Clinic named best US hospital for cardiology, heart surgery

Posted on July 27, 2021

Cleveland Clinic has been selected by U.S. News & World Report as the top U.S. hospital for cardiology and heart surgery, in... more

Patient autonomy to place do-not-resuscitate order low in COVID-19 hospitalization

Posted on July 27, 2021

Among high-risk patients, discussion of do-not-resuscitate orders should take place prior to hospitalization, as only 10% of patients possessed the autonomy to... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •  Doreen Tan

    Co Treasurer

      Doreen Su-Yin Tan is Associate Professor, Clinical & Pharmacy Practice, at the National University of Singapore. Affiliations (more…) more

  •  Jack Tan

    President

      Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Thomas Kahan

    President Elect

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •  Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more